InvestorsHub Logo
Followers 5
Posts 277
Boards Moderated 0
Alias Born 06/01/2014

Re: None

Tuesday, 11/20/2018 5:45:21 PM

Tuesday, November 20, 2018 5:45:21 PM

Post# of 2099
“Therefore, in addition to the ongoing OVAL trial we are exploring opportunities for investigator initiated trials of VB-111 in GBM and other oncology indications. We will elaborate on that in due time.”

Guess that answers my questions. Good to hear.